The society runs four biologics and biosimilars registers. Three are for adult patients receiving treatments for rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis, and the fourth is for young patients with juvenile idiopathic arthritis. The data collected from these registers generates vital evidence on patient safety in the long term as well as the efficacy of treatment.
We are keen to promote the use of data from the registers by other researchers who are not part of the core academic teams. You can apply for access to some of the data to enable important additional research and analysis by clicking here.
To access published papers relating to the registers, please click here